Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_6035_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
1
Добавлен:
15.09.2026
Размер:
16 Мб
Скачать
☆
 333
Prior research has documented that chrysophanol functions as an inhibitor of the
epidermal growth factor receptor/mammalian target of rapamycin pathway, displaying anticancer and anti-inammatory properties (Lee et al., 2011).
FIGURE 14.16 Polyketides penicitrinol G (41), penicitrinol H (42), chrysophanol (43), and (2,11-dihydroxy- 1-methoxycarbonyl-9-carboxylxanthone (44) isolated from fungus Penicillium citrinum.
⏎

14.3.4 NPS FROM PLANTS AS CATHEPSIN INHIBITORS

Several natural compounds isolated from various plants have demonstrated many inter­esting inhibitory activities against cathepsins. The first inhibitor was a member of the cystatin superfamily (Brzin et al., 1998). They were phytocystatin isolated from extract of red kidney bean (Phaseolus vulgaris L.). Phytocystatins are potent inhibitors of CPs produced by plants, forming strong and stable complexes with them. Phytocystatin was found to be a potent inhibitor of human Caths B, H, and L, with Ki values 3.6, 2.8, and
0.02 nM, respectively.
In their study , W isutsitthiwong et al. (201 1) explored the potential of 7-oxo-7-deacetox­ygedunin (7-OG), a limonoid of the gedunin type (Figure 14.17) derived from the seeds of the mangrove Xylocarpus moluccensis, as a potent inhibitor of osteoclastogenesis. Notably , 7-OG exhibited robust anti-osteoclastogenic activity with minimal cytotoxicity toward the
monocyte/macrophage progenitor cell line, displaying an IC50 of 4.14 μM. Treatment with
7-OG led to the complete suppression of Cath K mRNA expression. In-vitro experiments demonstrated that 7-OG effectively inhibited RANKL-induced osteoclast differentiation. These suppressive effects on osteoclast formation can be attributed, at least in part, to 7-OG’ s
ability to inhibit the NF-κB and MAPK pathways. Furthermore, the anti-osteoclastogenic activity of 7-OG is mediated, in part, by the suppression of NF-κB and MAPK pathways.
Investigation of downstream target genes revealed a complete downregulation of NFATc1
334 
and Cath K. Additionally, treatment with this limonoid inhibited RANKL-induced activa-
tion of p38, MAPK, and Erk, as well as the nuclear localization of NF-κB. Taken together, these ndings strongly suggest that 7-OG treatment interferes with osteoclast differentiation
at early stages following RANKL stimulation (Wisutsitthiwong et al., 2011). Limonoids hold promise as potential therapeutic agents for osteoclast-related disorders.
FIGURE 14.17 Chemical structure of limonoid 7-oxo-7-deacetoxygedunin (45) isolated from Xylocarpus moluccensis.
⏎
Dihydrochalcone and prenylated avone were identied from the bud of Artocarpus altilis (Patil et al., 2002). Traditionally in Taiwan, the buds have been reported to possess
anti-inammatory and detoxifying effects (Chen et al., 1993). All the compounds
extracted from A. altilis demonstrated signicant inhibition activity against Cath K covers (Figure 14.18). Compound (46) showed an IC50 value of 170 nM followed by compound (47) with an IC50 value of 98 nM. Compound (48) was moderated inhibitor of Cath K with IC50 values of 840 nΜ, respectively.
Biavones have been found to be potent inhibitors of Cath B and Cath K through random screening, with some degree of selectivity for Cath B. Biavone compounds were isolated and identied from acetone extracts of leaves and branches of Taxodium
mucronatum (Taxodiaceae) (49)–(51) and from methanol extracts of leaves of Cycas guizhouensis (Cycadaceae) (52)–(54) (Figure 14.19). Zeng et al. (2006) demonstrated
that biavones are a novel class of cathepsin inhibitors from plants and exhibit a greater degree of endopeptidase activity specically against Cath B. The kcat/Km value at pH 7.4
is much higher than that at pH 5.5, which means that, in weak neutral conditions, Cath B
can hydrolyze the endopeptidase substrate Z-FR-AMC more efciently. The pH preference of Cath B against the substrate Z-FR-AMC was investigated in a pH-dependent prole at
pH 7.4 compared to pH 5.5. IC50 results indicated that under weak neutral conditions, the
inhibitory activities of biavones are slightly more potent than those under acidic conditions.
At pH 5.5, the IC50 range was 0.81–1.17 µM, and at pH 7.4, the IC50 range was 0.23–0.68
µM. These biavones are reversible Cath B inhibitors, according to inhibition and exible
 335
docking experiments. The way these compounds bind and interact with Cath B makes them
effective inhibitors. According to the study, the new natural biavone inhibitors against
Cath B could open new strategies for developing innovative procedures for designing, creating, and screening inhibitors of Cath B (Pan et al., 2005; Kassem et al., 2004).
FIGURE 14.18 Chemical structures of dihydrochalcone (46)–(47) and prenylated flavones (48) isolated from Artocarpus altilis.
FIGURE 14.19 Chemical structures of biflavones isolated from Taxodium mucronatum (49)–(51) and Cycas guizhouensis (52)–(54).
⏎
⏎
The Brazilian Cerrado biome is situated in the Central Brazilian highlands, encom-
2
passing approximately 2 million km
, which accounts for 23% of Brazil’s total land area.
336 
It ranks as the second-largest vegetation formation on the South American continent, trailing only the Amazon rainforest (Ratter et al., 1997). Known for its high biodiversity, the Brazilian Cerrado is among the most diverse tropical savannas globally and represents an arid ecosystem inhabited by native species adapted to its seasonally variable climate. These woodland savannas are characterized by sparse canopies with scattered trees and shrubs, some of which are endemic to the region. The Cerrado’s remarkable environmental diversity positions it as one of the most biodiverse among all tropical savannas (Klink and Machado, 2005). The Cerrado is an important and rich source of plants with unstudied medicinal properties (Pinheiro and Monteiro, 2010). Ramalho et al. (2015) investigated
15 crude extracts from seven different Cerrado plants for the initial screening (125 µg/ mL). The most signicant inhibitory activity was observed in the ethanolic leaf extract of
Myrcia lingua Berg (Myrtaceae). The inhibition was higher than 90% against Caths L and B. Bioactivity-guided fractionation resulted in the isolation of seven active polyhydroxylated avonoids with and without glycosides (55)–(62) (Figure 14.20). The compounds showed slightly more potency against Cath B. The most active compounds were (59) and (60) with IC50 values of 4.9 and 8.2 µM, respectively. Polyhydroxylated avonols were shown to
be uncompetitive inhibitors against Cath B. Additionally, other avonoids isolated from
Esenbeckia grandiora Mart. (Rutaceae), Vochysia thyrsoidea Pohl. (Vochysiaceae), and Byrsonima coccolo bifolia Kunth. (Malpighiaceae) were also evaluated for their inhibitory
activity against Cath B but did not show signicant inhibition at a concentration of 100 µM.
FIGURE 14.20 Chemical structures of polyhydroxylated flavonols (55)–(62) from Myrcia lingua Berg.
⏎
Rhizoma Drynariae (DR), usually named “Gol-Se-Bo” in Korean and “Gu-Sui-Bu” in Chinese folk medicine, is one of the most frequently used herbs in traditional medi­cine for treating bone-related diseases. The biological effects of DR on in-vitro bone cell culture, assessment of Cath K processing in bone cells, and examination of DR’s antibone resorption activity have been investigated by analyzing inhibitory enzymatic activity (Jeong et al., 2003). Dioscin (DR) demonstrates the potential to affect bone cell culture
without inducing cytotoxicity. The most efcacious concentration of DR for bone cells was determined to be 100 µg/mL. When osteoclasts and osteoblasts, both types of bone cells,
were exposed to the PI3-kinase inhibitor wortmannin (WT), it resulted in the inhibition of intracellular Cath K maturation. Likewise, the application of DR extracts to osteoclasts containing long bone cells prevented the intracellular maturation of Cath K, indicating
 337
that DR may impede the intracellular trafcking of pro-Cath K. The researchers conducted
experiments with WT and DR in the presence or absence of the mannose-6-phosphate (M6P) receptor. Inhibition of Cath K in in-vitro bone resorption processing by both WT and DR was observed in a dose-dependent manner, with similar potency observed for the inhibition of Cath K processing.
The compounds Kushennol F (63) and Sohoravanone G (64) were isolated and identi-
ed from DR (Qiu et al., 2016) (Figure 14.21). Molecular docking and dynamics methods
showed that both compounds interact with Cath K. These compounds exhibited inhibitory effects on the bone resorption process associated with Cath K. Biological studies were conducted to verify the effects of these compounds on Cath K and its related bone resorption process. Kushennol F (63) and Sohoravanone G (64) exhibited inhibitory activity against Cath K, with IC50 values of 8.80 and 27.24 µM, respectively. The biological actions of KF
and SG on pit formation by osteoclasts were further conrmed using cultured RANKL-
induced osteoclastogenesis cells. The results clearly indicated that Kushennol F (63) and Sohoravanone G (64) strongly suppressed osteoclastogenesis and inhibited Cath K-related
bone resorption. Signicantly, these two naturally derived compounds from plants have
displayed promising potential as novel inhibitors of Cath K, making them valuable for potential applications in osteoporosis management.
FIGURE 14.21 Chemical structures of Kushennol F (63) and Sohoravanone G (64) isolated from DR.
⏎
The hexane and ethyl acetate (EtOAc) extracts of the stems of Bowdichia virgilioides
Kunth (Fabaceae) were assayed against Caths K, L, and V at a concentration of 125 µg/mL.
The extract with lower polarity (hexane) exhibited noteworthy inhibition against Caths L and V, showing inhibitions of 91% and 97%, respectively . Similarly, the EtOAc extract displayed inhibitory effects on Caths K, L, and V, with inhibitions of 70%, 97%, and 99%, respectively. Bioassay-guided fractionation of the hexane and EtOAc extracts allowed the characterization of lupeol, lupenone, β-sitosterol, and stigmasterol in mixture, a trans-p-coumaric acid ester derivative, syringaresinol, bowdenol, 8-methoxycoumestrol, 3,4-hydroxy-7-methoxyiso­avone, 7,3′-dihydroxy-4′-methoxyisoavone, and 5,4′-dihydroxy-7′-methoxyisoavone.
338 
All isolated compounds were tested at an initial concentration of 50 µg/mL against Caths K,
L, and V. The most potent compounds were the trans-p-coumaric acid ester derivative (65) and 8-methoxycoumestrol (65) (Figure 14.22). The derivative of trans-p-coumaric acid (65) displayed 78% inhibitory activity on Cath L, 94% inhibition on Cath V, and 49% inhibition on Cath K. Likewise, 8-methoxycoumestrol (66) showed 55% inhibitory activity on Cath L, 78% inhibition on Cath V, and 35% inhibition on Cath K. Similarly, the EtOAc fraction from B. virgilioides containing similar phenolic compounds (8-methoxycoumestrol and
isoavones) showed inhibition on Cath K, L, and V of 70%, 97%, and 99%, respectively, at a concentration of 125 µg/mL. The enzyme inhibitory activity of 8-methoxycoumestrol (67)
was determined for Cath V, showing an IC50 value of 17.4 µM (Silva et al., 2019).
FIGURE 14.22 Chemical structures of trans-p-coumaric acid ester derivative (65) and 8-methoxycoumestrol (66) isolated from Bowdichia virgilioides Kunth.
⏎
Similarly, chalcone derivatives (67–70) were extracted from the ethanol extract of the inner bark of Myracrodruon Urundeuva Allemão and individually assessed for their inhibitory activity against Cath V (Sarria et al., 2018) (Figure 14.23). Compound (67)
exhibited the highest inhibitory potency, with an IC50 value of 0.42 μM. Additionally, compounds (66) and (68) displayed signicant inhibition, with IC50 values of 0.7 and 1.4 μM, respectively. In contrast, compound (69) exhibited only moderate inhibition, with an IC50 value of 24 μM. Notably, this marks the rst instance of dimeric chalcones being identied as inhibitors of Cath V.
Natural polycyclic polyprenylated benzophenones (71)–(73) were isolated from Garcinia brasiliensis (Martins et al., 2009) (Figure 14.24). Guttiferone A (71) showed inhibition against Cath G, with an IC50 value of 2.7 µM, which is quite similar to the clas­sical inhibitor chymostatin (2.1 µM) for this peptidase. Inhibition on Cath B was observed at 2.1 µM. The presence of both the bicycle[3.3.1]-nonanetrione and 13,14-dihydroxy substituted phenyl groups, as well as the keto-enol tautomeric form where the bridge carbon is hydroxylated, enhances the inhibitory activity of the enzyme. The derivatives of polyisoprenylated benzophenones that contain the bicycle[3.3.1]-nonanetrione moiety have been shown to inhibit DNA topoisomerases and telomerase, as well as act as regulators in mitogen-activated protein (MAP) kinase signal transduction pathways. The bicycle[3.3.1]­nonanetrione is useful for antineoplastic therapy by decreasing the activity of MAP kinases during mitosis in cancerous and tumoral tissues.
 339
FIGURE 14.23 Chemical structures of chalcone derivatives (67)–(70) isolated from Myracrodruon urundeuva Allemão.
FIGURE 14.24 Chemical structures of polycyclic polyprenylated benzophenones (71)–(73) isolated from
Garcinia brasiliensis.
⏎
⏎
A compound library consisting of 270 chemical structures, including 111 NPs isolated from Brazilian plants, was investigated through high-throughput screening to identify new
340 
potent inhibitors of Caths K, V, L, and S (Severino et al., 2011). This study evaluated a series of different classes of secondary metabolites, including alkaloids, coumarins,
triterpenes, cinnamic acids, amides, lignans, avonoids, and limonoids. The most prom­ising results against the cathepsins were obtained for alkaloid and avonoid derivatives. Severino et al. (2011) described the rst study in the literature to use NPs as reversible and
competitive inhibitors of Cath V. A series of acridone alkaloids (75)–(86) isolated from the methanol extract of the stem bark of Swinglea glutinosa showed potent inhibitory activity (Figure 14.25). The alkaloids were found to be reversible and competitive inhibitors of Cath V . Acridone (80) was the most effective inhibitor with an IC50 value of 1.2 µM and Ki of 200 nM. The inhibitor interacts with the enzyme’s amino acids through hydrogen bonds and van der Waals interactions. The predicted conformation within the binding pocket of Cath V revealed that the inhibitor interacts via four hydrogen bonds. First, the 1-hydroxyl substituent acts as a hydrogen bond donor to the main-chain carbonyl group of Gly23 at the S1 pocket. Second, the oxygen atom of the 2-methoxy substituent accepts a hydrogen bond from the NH2 side-chain of Gln19, which forms part of the oxyanion hole in Cath V. Third, the 5-hydroxyl substituent binds to the S2 pocket, acting as a hydrogen bond donor to the main-chain carbonyl group of Leu157. Finally , the 9-carbonyl group binds to the S3 pocket by accepting a hydrogen bond from the NH main-chain of Gly66. In addition to these polar contacts, nonpolar interactions also contribute to the orientation of the inhibitor in Cath V. The side-chains of Phe67 and Cys25 form van der Waals interactions with the
1-hydroxyl and 2,3,4-trimethoxy substituted rings, respectively. The SAR data conrms
that the inhibitory activity is improved by the presence of polar substituents at R1 (2-posi­tion) and less bulky groups at R4 (8-position).
Considering the signicant challenge of nding selective cathepsin inhibitors, a
complementary database for a small series of acridone alkaloids (74)–(84) was evaluated
against Cath L (Marques et al., 2016). The compounds showed signicant inhibition of
Cath L, with IC50 values ranging from 0.8 to 57 μM. Alkaloids (74), (75), and (80) were the most potent in the series, with IC50 values of 0.9, 0.8, and 1.5 μM, respectively. For Cath V, the IC50 values ranged from 1.2 to 48.0 μM, with compounds (76), (79), and (80) being the most potent, with IC50 values of 2.2, 2.2, and 1.2 μM, respectively. The selectivity observed in this small series was low, suggesting that these inhibitors are not capable of selectively inhibiting Caths L and V. However, important information from the SAR data could be visualized. The comparison of compounds (74) and (76) shows that the potency of these compounds is not affected by the presence of the prenyl substituent group at C-8 in ring A. Similarly, the same is observed when comparing compounds (74) and (75) in terms of the presence of a methoxy group at C-4. Analyzing compounds (76) and (77), it was observed
that the inclusion of the prenyl group at C-4 of ring B leads to a signicant decrease in
potency by a factor of approximately 12 times. On the other hand, the absence of the prenyl group at C-2 of ring B in compound (77) suggests that this group is crucial for establishing afnity with these cathepsins. The intramolecular cyclization of the prenyl group (80), (82), (83), and (84) signicantly reduces the potency of the compounds compared to prenylated alkaloids (74), (75), (76), and (77), suggesting that the formation of a fourth ring hinders the interaction of the inhibitor with the catalytic site. The data suggest that the acridone alkaloids are satisfactorily positioned in the region of the enzyme’s catalytic site, allowing
 341
for important intermolecular interactions for molecular recognition. The aromatic rings A and B can favor hydrophobic and van der Waals interactions, although this effect is less pronounced in the case of tetracyclic compounds that hinder the planarity of the molecule and, consequently, the hydrophobic interaction. Acridone alkaloids represent a potential lead candidate for future medicinal chemistry, serving as new competitive inhibitors with
improved potency and afnity against Caths V and L.
FIGURE 14.25 Chemical structures of a series of acridone alkaloids (74)–(84) isolated from Swinglea glutinosa.
Triterpenoids have been identied as a new class of competitive inhibitors against
Cath L. Ramalho et al. (2014) have screened several natural triterpenes isolated from plants (Figure 14.26). Three natural triterpenes, namely, 3-O-acetylursolic acid (85), ursolic acid (86), and 3-epiursolic acid (87), were extracted from the stems of Myrcia
lingua Berg (Myrtaceae). 3-Oxoursolic acid (88) was identied from the stem bark of Vochysia thyrsoidea (Vochysiaceae). Masticadienoic acid (89) and schinol (90) were isolated from the fruit of Schinus terebinthifolius (Anacardiaceae). Interesting, the
⏎
342 
evaluated triterpenoids did not show signicant inhibition on Cath B (IC50 ˃ 250 µM).
Molecular docking studies and analysis of the binding patterns and interaction modes on Cath B revealed that due the size and rigidity of the triterpenoid ring systems, they cannot pass through the narrow V-shaped channel in the enzyme’s active site. Consequently, the structure is unable to interact with the amino acids in subsites S2 and S3, which are crucial for the inhibitory activity. On the other hand, triterpenoids were active against Cath L. The most promising was 3-epiursolic acid (87) with IC50 values of 6.5 μM on Cath L. 3-O-acetylursolic acid (85) and ursolic acid (86) showed signicant inhibition on Cath L with IC50 value of 12.3 and 39.5 µM. The moderate inhibitory activity exhibited by triterpenoids against Cath L suggests their potential to greatly assist in the development of new inhibitors with increased potency against this enzyme (Ramalho et al., 2014).
FIGURE 14.26 Chemical structures of triterpenoids (85)–(90) isolated from different plants.
⏎
The dipeptide asperphenamate (91) was isolated from raw malt, a traditional medicine used for the treatment of mammary gland hyperplasia (Ling et al., 2005) (Figure 14.27). Asperphenamate (91) can inhibit the proliferation of cancer cells and showed cell death through the induction of autophagy (Yuan et al., 2012). The inhibition of cathepsin by asperphenamate (91) against Caths L, S, K, and B was evaluated, showing a moderate inhibitory effect on Caths L and S with IC50 values of 91.23 and 171.11 µM, respectively (Li et al., 2021; Yuan et al., 2018).
EBOV and Marburg virus (MARV) are members of the Filoviridae family, known for causing severe hemorrhagic fevers in both humans and nonhuman primates, often with mortality rates as high as 90%. In a study conducted by Cui et al. (2018), researchers prepared 373 extracts from plants commonly used in traditional Chinese herbal medicine